| A comprehensive analysis of the efficacy and safety of COVID-19 vaccines C Cai, Y Peng, E Shen, Q Huang, Y Chen, P Liu, C Guo, Z Feng, L Gao, ... Molecular Therapy 29 (9), 2794-2805, 2021 | 159 | 2021 |
| Patient-derived xenograft models in cancer therapy: technologies and applications Y Liu, W Wu, C Cai, H Zhang, H Shen, Y Han Signal Transduction and Targeted Therapy 8 (1), 160, 2023 | 94 | 2023 |
| The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma G Deng, S Zeng, J Ma, Y Zhang, Y Qu, Y Han, L Yin, C Cai, C Guo, ... Scientific reports 7 (1), 41616, 2017 | 86 | 2017 |
| BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma J Ma, S Zeng, Y Zhang, G Deng, Y Qu, C Guo, L Yin, Y Han, C Cai, Y Li, ... Cancer Letters 411, 117-129, 2017 | 71 | 2017 |
| Knockdown of Beclin‐1 impairs epithelial‐mesenchymal transition of colon cancer cells H Shen, L Yin, G Deng, C Guo, Y Han, Y Li, C Cai, Y Fu, S Liu, S Zeng Journal of Cellular Biochemistry 119 (8), 7022-7031, 2018 | 59 | 2018 |
| Honokiol induces ferroptosis in colon cancer cells by regulating GPX4 activity C Guo, P Liu, G Deng, Y Han, Y Chen, C Cai, H Shen, G Deng, S Zeng American journal of cancer research 11 (6), 3039, 2021 | 52 | 2021 |
| ZEB1 promotes oxaliplatin resistance through the induction of epithelial-mesenchymal transition in colon cancer cells C Guo, J Ma, G Deng, Y Qu, L Yin, Y Li, Y Han, C Cai, H Shen, S Zeng Journal of Cancer 8 (17), 3555, 2017 | 49 | 2017 |
| BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial–mesenchymal transition via upregulating ID2 S Zeng, Y Zhang, J Ma, G Deng, Y Qu, C Guo, Y Han, L Yin, C Cai, Y Li, ... Cancer letters 390, 67-76, 2017 | 45 | 2017 |
| BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation G Deng, S Zeng, Y Qu, Q Luo, C Guo, L Yin, Y Han, Y Li, C Cai, Y Fu, ... Journal of Experimental & Clinical Cancer Research 37, 1-13, 2018 | 38 | 2018 |
| A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy C Cai, D Tang, Y Han, E Shen, O Abdihamid, C Guo, H Shen, S Zeng Aging (Albany NY) 12 (18), 18741, 2020 | 37 | 2020 |
| FOXC2 promotes oxaliplatin resistance by inducing epithelial-mesenchymal transition via MAPK/ERK signaling in colorectal cancer Y Chen, G Deng, Y Fu, Y Han, C Guo, L Yin, C Cai, H Shen, S Wu, S Zeng OncoTargets and therapy, 1625-1635, 2020 | 36 | 2020 |
| MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling Y Han, Y Peng, Y Fu, C Cai, C Guo, S Liu, Y Li, Y Chen, E Shen, K Long, ... Advanced science 7 (13), 2000112, 2020 | 34 | 2020 |
| tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner Y Han, Y Peng, S Liu, X Wang, C Cai, C Guo, Y Chen, L Gao, Q Huang, ... Journal of Experimental & Clinical Cancer Research 41 (1), 32, 2022 | 33 | 2022 |
| Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients E Shen, Y Han, C Cai, P Liu, Y Chen, L Gao, Q Huang, H Shen, S Zeng, ... Aging (Albany NY) 13 (5), 7570, 2021 | 32 | 2021 |
| CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma M He, Y Han, C Cai, P Liu, Y Chen, H Shen, X Xu, S Zeng Journal of Cellular and Molecular Medicine 25 (7), 3391-3399, 2021 | 28 | 2021 |
| M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer C Cai, J Long, Q Huang, Y Han, Y Peng, C Guo, S Liu, Y Chen, E Shen, ... Frontiers in Oncology 11, 615296, 2021 | 22 | 2021 |
| BMP4 promotes the metastasis of gastric cancer by inducing epithelial–mesenchymal transition via ID1 G Deng, Y Chen, C Guo, L Yin, Y Han, Y Li, Y Fu, C Cai, H Shen, S Zeng Journal of cell science 133 (11), jcs237222, 2020 | 21 | 2020 |
| Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality C Cai, X Zhang, Y Liu, E Shen, Z Feng, C Guo, Y Han, Y Ouyang, H Shen Gut Pathogens 13, 1-12, 2021 | 18 | 2021 |
| The efficacy of COVID-19 vaccines against the B. 1.617. 2 (delta) variant C Cai, Y Liu, S Zeng, H Shen, Y Han Molecular Therapy 29 (10), 2890-2892, 2021 | 18 | 2021 |
| The landscape of COVID-19 in cancer patients: prevalence, impacts, and recommendations O Abdihamid, C Cai, L Kapesa, S Zeng Cancer Management and Research, 8923-8933, 2020 | 17 | 2020 |
